Effects of the butylated hydroxyanisole and butylated hydroxytoluene on the DNA adduct formation and arylamines N-acetyltransferase activity in human colon tumor cells.
The effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on N-acetyltransferase (NAT) activity were examined using a human colon tumor cell line (colo 205). BHA or BHT were added to the cytosols or to the medium of human colon tumor cells: The NAT activity was measured by high performance liquid chromatography, assaying the amounts of acetylated 2-aminoflluorene (AAF), p aminobenzoic acid (N-Ac-PABA), nonacetylated 2 aminofluorene (AF) and p-aminobenzoic acid (PABA). The NAT activity in the human colon tumor cells and cytosols was suppressed by BHA or BHT in a dose-dependent manner. The apparent values of Km and Vmax of NAT of human colon tumor cells were also decreased by BHA or BHT in cytosols and in intact cells. BHA or BHT may act as a noncompetitive inhibitor. After the incubation of human colon tumor cells with AF in the presence of BHA or BHT, the cells were recovered and DNA was prepared and hydrolysed to nucleotides. Adducted nucleotides were extracted into butanol and AF-DNA adducts were analysed by HPLC. The results also demonstrated that when BHA or BHT was added to the media, a decrease in AF-DNA adduct formation was seen in the human colon tumor cells. The finding of AF-DNA adduct formation in cultured human colon tumor cells suggest the possibility of using cultured cells for assessing arylamine-induced DNA damage.
Chang
S H
SH
Department of Microbiology, China Medical College, 91, Hsueh-Shih Road, 400, Taiwan, Republic of China.
Chen
G W
GW
Yeh
C C
CC
Hung
C F
CF
Lin
S S
SS
Chung
J G
JG
D015073:2-Acetylaminofluorene / Q000378:metabolism; D010129:4-Aminobenzoic Acid / Q000378:metabolism; D000975:Antioxidants / Q000494:pharmacology*; D001191:Arylamine N-Acetyltransferase / Q000378:metabolism*; D002083:Butylated Hydroxyanisole / Q000494:pharmacology*; D002084:Butylated Hydroxytoluene / Q000494:pharmacology*; D002273:Carcinogens / Q000494:pharmacology*; D003110:Colonic Neoplasms / Q000188:drug therapy*; D018736:DNA Adducts; D006801:Humans; D007700:Kinetics; D013997:Time Factors; D014407:Tumor Cells, Cultured; D062366:para-Aminobenzoates
D000975:Antioxidants; D002273:Carcinogens; D018736:DNA Adducts; D062366:para-Aminobenzoates; C023730:Acedoben; D002084:Butylated Hydroxytoluene; D002083:Butylated Hydroxyanisole; D015073:2-Acetylaminofluorene; D001191:Arylamine N-Acetyltransferase; D010129:4-Aminobenzoic Acid